Invest Follow Following Unfollow

UDENZ

udenz.ae/

by UDENZ LABZ

Contact Me

Request Meeting Request Call Request Business Plan Message Entrepreneur

Raising

889,850
Raised
905,516

33 investors

Invest Now

Follow Following Unfollow

Join 33 others & invest in UDENZ

Early Adoption Discount

1st.

First Tranche

Shares will be sold at a 0 % discount

RM0 share value remaining

RM4.44 Price/Share

2nd.

Second Tranche

Shares will be sold at a 15 % discount

RM0 share value remaining

RM3.78 Price/Share

3rd.

Third Tranche

Shares will be sold at a 10 % discount

RM0 share value remaining

RM4 Price/Share

4th.

Fourth Tranche

Shares will be sold at a 5 % discount

RM0 share value remaining

RM4.22 Price/Share

Minimum investment size 500

How much do you want to invest?

Available for investment $96,479

Number of shares to be purchased

Price/Share before discount

Note: This proposal accepts overfunding; remember it is optional whether the proposal owner decides to accept any overfunding commitments.

I acknowledge that my investment will be irrevocably committed to the proposal should it reach its minimum target amount as indicated in the term sheet. I understand that this minimum funding threshold is a lower figure than the 100% funding target

By ticking this box I confirm that I understand the nature of the investment being made and I agree to the investor's terms of business .

I have read the risks disclosure document and fully understand and accept the risks of investing in private companies.

Invest Cancel

Why UDENZ ?

Why invest?

Notable Press

www.khaleejtimes.com/business/technology/now-an-app-will-guide-you-to-nearest-dentist www.forbesmiddleeast.com/en/lists/people/pname/udenz/pid/90789/

Read the full risk warning

The Investors

2 new

SEHTEQ

Platinum Investor

Elle

Platinum Investor

saif.aljaibeji

Gold Investor

View All Investors

Join us to see more

Please login/register to see the Proposal Forcasts/Financials.

Latest Update

View all Updates

The Team

Dr. Hisham Safadi

Founder and CEO

Manoj Aheeray

Founder

Dr.Saad Al Sogair

Co-Founder

Dr.Atul Anant Aundhekar

Co-Founder

Meet the Team

UDENZ is a unique web & mobile dental platform that enables patients to easily search, compare and book dental appointments

Watch the video Download the documents

Proposal ID: 10559
Closing date: 6 Sep 2017
Category: Healthcare, Health... Healthcare, Health & Fitness
Tags: Crowd Investing ... Crowd Investing, Experienced founder, Health, Healthcare, Platform, Tech, UAE
Stage: Overfunded
location: United Arab Emirates - Dubai

Presence:

Read the full risk warning

Why UDENZ ?

• The only dental-dedicated digital healthcare platform for both dentists and patients.

• Spearheaded by a renowned GCC dentist, Dr. Hisham Safadi, who has led several health care projects in the UAE treating over 500,000 patients.

• Available in 12 countries and 16 cities just a few months after launching in March 2016, with over 700 dentists and 50 hospitals listed on the platform.

• Listed as one of Forbes Middle East’s Top 50 Startups To Watch.

• Received media attention from Khaleej Times, Arabian Business and Bloomberg Business.

Notable Press

www.khaleejtimes.com/business/technology/now-an-app-will-guide-you-to-nearest-dentist www.forbesmiddleeast.com/en/lists/people/pname/udenz/pid/90789/

The Business

Join us to see more

Please Login/register to see the proposal business.

UDENZ began after our founder, Dr. Hisham Safadi, was unable to find a comprehensive solution to his mother’s dental problems. He decided to develop a turn-key interactive medical solution in order to meet the needs of dental patients across the region.

In 2015 there were approximately 5 million private dental appointments in the UAE with a further 19 million in the GCC. Combine this with little to no comprehensive dental information online, further highlighted the need for a digital solution.

Using UDENZ, patients now have access to a large network of qualified dentists, with reviews and accreditations to identify the right practitioner for their procedure. The app provides real-time information on available appointments and allows patients to book with just the click of a button greatly reducing time spent searching and booking an appointment.

Yet the platform itself does not only cater to patients as it also offers dentists a great way to increase their exposure, reach new patients and directly engage with current patients. Which in turn will improve the operational efficiency of their practice and enable them to sustain long-standing relationships with their patients.

Highly experienced and renowned UAE dentist, Dr. Hisham Safadi, who has treated over 500,000 patients since 2007, he founded UDENZ after experiencing firsthand the difficulties both dentists and dental patients experience.

To accomplish this, he has built a team comprised of corporate finance experts, innovative entrepreneurs, and app developers from across the world who aim to capitalize on the growing dental market in the GCC and beyond.

Since it’s inception in February 2016, UDENZ has launched in 16 different cities in 12 different countries and aims to expand its offering, scope, and availability over the next 3-5 years.

We are looking to raise $200,00, with a minimum target of $125,000 via the Eureeca platform. $75,000 of this has already been committed via strategic partners in the UAE.

The funds will be raised to:

• Aggressively scale territories: MENA and GCC dominance
• Evolve business model and e-commerce engine
• Continuously improve product range
• Expand to UK & Europe
• Add another medical specialty to the platform
• Finalize strategic partners across MENA and GCC

Should we only raise our minimum, we will not be expanding to the UK and Europe until our next round of financing.

This proposal has a minimum target of RM556,156 and will be marked as successful once that target is reached.

The following exit strategies have been considered and approved by the Board of Directors:

1. A Share Buyback will be offered to all shareholders investing in this round five years following the issuance of shares. The price per share at which the Buyback will be offered shall be determined based on the market value of the Company at that point.

2. Finally, we anticipate a possible acquisition by a global competitor-taking place over the next 5-7 years, which is very likely to yield a high multiple exit to any shareholders present at the time.

Public documents